Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Heart Arrest D006323 13 associated lipids
Cystitis D003556 23 associated lipids
Cholecystitis D002764 8 associated lipids
HIV Infections D015658 20 associated lipids
Subacute Sclerosing Panencephalitis D013344 3 associated lipids
Dermatitis, Allergic Contact D017449 20 associated lipids
AIDS Dementia Complex D015526 4 associated lipids
Constriction, Pathologic D003251 8 associated lipids
Medulloblastoma D008527 22 associated lipids
Zellweger Syndrome D015211 39 associated lipids
Coronary Thrombosis D003328 7 associated lipids
Glomerulonephritis, Membranous D015433 6 associated lipids
Peripheral Vascular Diseases D016491 8 associated lipids
Bronchopulmonary Dysplasia D001997 4 associated lipids
Hypertension, Portal D006975 12 associated lipids
Atherosclerosis D050197 85 associated lipids
Leukemia-Lymphoma, Adult T-Cell D015459 25 associated lipids
Metabolic Syndrome D024821 44 associated lipids
Dyslexia D004410 3 associated lipids
Leukemia, Eosinophilic, Acute D015472 3 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Ferreira MG and Fonteles MC Different classes of PAF-antagonists block norepinephrine-induced vascular escape and tachyphylaxis in the isolated rabbit kidney. 1996 Res. Commun. Mol. Pathol. Pharmacol. pmid:8987112
Dupuis F et al. Production and metabolism of platelet-activating factor by human bone marrow cells. 1997 Res. Immunol. pmid:9226766
Denizot Y et al. Modulation of gut wall paf-acether and precursors by intestinal microflora. 1990 Mar-Apr Res. Immunol. pmid:2218055
Denizot Y et al. Effects of platelet-activating factor on human T and B cells--an overview. 1994 Res. Immunol. pmid:8079043
Alviano DS et al. Differentiation of Fonsecaea pedrosoi mycelial forms into sclerotic cells is induced by platelet-activating factor. 2003 Res. Microbiol. pmid:14643407
Muehlmann LA et al. PAF increases phagocytic capacity and superoxide anion production in equine alveolar macrophages and blood neutrophils. 2012 Res. Vet. Sci. pmid:21820686
Conejeros I et al. 2-Aminoethoxydiphenyl borate (2-APB) reduces respiratory burst, MMP-9 release and CD11b expression, and increases l-selectin shedding in bovine neutrophils. 2012 Res. Vet. Sci. pmid:21071047
Fairbairn SM et al. Effects of platelet activating factor on the distribution of radiolabelled leucocytes and platelets in normal horses and asymptomatic horses with chronic obstructive pulmonary disease. 1996 Res. Vet. Sci. pmid:8880978
Foster AP et al. Platelet activating factor is a mediator of equine neutrophil and eosinophil migration in vitro. 1992 Res. Vet. Sci. pmid:1332153
Bailey SR et al. Actions and interactions of ADP, 5- HT, histamine and PAF on equine platelets. 2000 Res. Vet. Sci. pmid:10756136
Hammond A et al. Platelets in equine recurrent airway obstruction. 2007 Res. Vet. Sci. pmid:17107696
Jarvis GE and Evans RJ Endotoxin-induced platelet aggregation in heparinised equine whole blood in vitro. 1994 Res. Vet. Sci. pmid:7871251
Marr KA et al. Effect of antigen challenge on the activation of peripheral blood neutrophils from horses with chronic obstructive pulmonary disease. 1997 May-Jun Res. Vet. Sci. pmid:9300544
Akbarshahi H et al. Acute lung injury in acute pancreatitis--awaiting the big leap. 2012 Respir Med pmid:22749752
Echazarreta AL et al. Lack of systemic oxidative stress during PAF challenge in mild asthma. 2005 Respir Med pmid:15823446
Kroegel C et al. Cytokines, platelet activating factor and eosinophils in asthma. 1992 Respir Med pmid:1462017
Barnes NC New developments in the treatment of asthma and chronic obstructive pulmonary disease. 1993 Respir Med pmid:7901879
Inoue T and Kannan MS Platelet-activating factor-induced functional changes in the guinea pig trachea in vitro. 1989 Respir Physiol pmid:2781159
Marcano H et al. Effect of dopamine on platelet activating factor induced-pulmonary edema in isolated and perfused rabbit lungs. 2001 Respir Physiol pmid:11348642
Pesce L et al. Effect of Fenoterol on PAF-induced lung edema in isolated and perfused rabbit lungs. 1998 Respir Physiol pmid:9865589
Friedman E et al. Effect of hydrocortisone on platelet activating factor induced lung edema in isolated rabbit lungs. 2000 Respir Physiol pmid:10786645
Steer ML Relationship between pancreatitis and lung diseases. 2001 Respir Physiol pmid:11535257
Raj JU et al. Effects of endothelin, platelet activating factor and thromboxane A2 in ferret lungs. 1992 Apr-May Respir Physiol pmid:1626132
Rastogi P and McHowat J Inhibition of calcium-independent phospholipase A2 prevents inflammatory mediator production in pulmonary microvascular endothelium. 2009 Respir Physiol Neurobiol pmid:19059366
Machado GB et al. Pseudomonas aeruginosa toxin ExoU induces a PAF-dependent impairment of alveolar fibrin turnover secondary to enhanced activation of coagulation and increased expression of plasminogen activator inhibitor-1 in the course of mice pneumosepsis. 2011 Respir. Res. pmid:21819560
Jiang Z et al. The effect of lipoprotein-associated phospholipase A2 deficiency on pulmonary allergic responses in Aspergillus fumigatus sensitized mice. 2012 Respir. Res. pmid:23140447
Gebremichael I and Leuenberger P Platelet-activating factor does not induce bronchial hyperreactivity in nonasthmatic subjects. 1992 Respiration pmid:1485002
Block LH et al. PAF-dependent phosphatidylinositol turnover in platelets: differences between asthmatics and normal individuals. 1990 Respiration pmid:2099571
Tohda Y et al. Role of chemical mediators in airway hyperresponsiveness in an asthmatic model. 2001 Respiration pmid:11223734
Matheson MJ et al. Role of platelet activating factor, leukotrienes and polymorphs in the FMLP induced increase in microvascular leakage in rabbit trachea. 1997 Respirology pmid:9424405
Li HP et al. Effect of chinonin on acute hypoxic pulmonary vasoconstriction in Sprague-Dawley rats. 1998 Respirology pmid:9692515
Ruchaud-Sparagano MH et al. Effect of granulocyte-macrophage colony-stimulating factor on neutrophil function in idiopathic bronchiectasis. 2013 Respirology pmid:23730995
Hosford D et al. Platelet-activating factor and cytokine interactions in shock. 1989 Resuscitation pmid:2555874
Gedeborg R and Wiklund L Experimental model of cardiovascular post-resuscitation syndrome--no effect of platelet activating factor antagonism. 1998 Oct-Nov Resuscitation pmid:9918458
Egido J et al. [The participation of platelet-activating factor and cytokines in the pathogenesis of glomerular damage]. 1990 Jul-Aug Rev Clin Esp pmid:2284487
Fité-Mora R Torsade de pointes associated with rupatadine. 2009 Rev Esp Cardiol pmid:19268083
Ais JG et al. [The physiopathology of acute pancreatitis: the role of platelet-activating factor (PAF)]. 1992 Rev Esp Enferm Dig pmid:1547030
Martin JG [Animal models of bronchial hyperreactivity]. 1994 Rev Mal Respir pmid:7515508
Nechifor M [Agonists and antagonists of the platelet activating factor (PAF)]. 1989 Oct-Dec Rev Med Chir Soc Med Nat Iasi pmid:2636782
Cijevschi I and Cijevschi D [Ocular immunopathological characteristics and the involvement of the platelet-aggregation factor and the anti-PAF at the level of the eye]. 1999 Jan-Jun Rev Med Chir Soc Med Nat Iasi pmid:10756889
Nechifor M [Agonists and antagonists of the platelet activating factor (PAF). II]. 1990 Apr-Jun Rev Med Chir Soc Med Nat Iasi pmid:2100870
Leclercq M et al. [Effects of Hymenoptera stings: physiopathology and immunology according to recent literature findings]. 1985 Rev Med Liege pmid:2418479
Santos OF et al. [Platelet activating factor in nephrology: physiopathologic and therapeutic perspectives]. 1988 Jul-Aug Rev Paul Med pmid:3076976
Massion PB and Frans A [Role of platelet activating factor and its antagonists in bronchial asthma]. 1992 Rev Pneumol Clin pmid:1384101
Charbonneau P and Suisse A [Syndrome of multiple organ failure]. 1990 Rev Prat pmid:2263856
Romero A et al. [Effect of corticosteroids, quinacrine and L-652, 731 on experimental aggregation of polymorphonuclear leukocytes induced by complement and platelet activating factor (PAF)]. 1988 Rev. Esp. Fisiol. pmid:3072620
Santos JC et al. Effect of intrarenal infusion of synthetic PAF-acether in dogs. 1988 Rev. Esp. Fisiol. pmid:3231880
Brochet B et al. [Pilot study of Ginkgolide B, a PAF-acether specific inhibitor in the treatment of acute outbreaks of multiple sclerosis]. 1992 Rev. Neurol. (Paris) pmid:1439458
Simmet T and Peskar BA Eicosanoids and the coronary circulation. 1986 Rev. Physiol. Biochem. Pharmacol. pmid:3520775
Sperling RI Dietary omega-3 fatty acids: effects on lipid mediators of inflammation and rheumatoid arthritis. 1991 Rheum. Dis. Clin. North Am. pmid:1862246
Tunc SE et al. Platelet-activating factor and P-selectin activities in thrombotic and nonthrombotic Behçet's patients. 2005 Rheumatol. Int. pmid:15004723
Su J et al. Natural antibodies against phosphorylcholine as potential protective factors in SLE. 2008 Rheumatology (Oxford) pmid:18522961
Lima MC et al. Mediators of inflammation and antagonism of experimental pleurisy in the rat by fenspiride. 1988 Rhinol. Suppl. pmid:2907679
Ganbo T et al. Platelet activating factor (PAF) effects on ciliary activity of human paranasal sinus mucosa in vitro. 1991 Rhinology pmid:1947682
Ganbo T et al. Turn-over of PAF in cultures of human paranasal sinus mucosa. 1994 Rhinology pmid:7839082
Takahashi H et al. [Blood coagulation disorders in thrombotic thrombocytopenic purpura--with special reference to a von Willebrand factor abnormality]. 1987 Rinsho Byori pmid:3501812
Oda M et al. [Platelet-activating factor producing cell--target cell interactions]. 1989 Rinsho Byori pmid:2754814
Oura Y [The effects of platelet-activating factor (PAF) on the collagen-induced whole blood aggregation]. 1994 Rinsho Byori pmid:8107285
Maki N et al. [Analysis of platelet-activating factor and its effect on the lung]. 1993 Rinsho Byori pmid:8361018
Matsuno K et al. [Cytoplasm free calcium ions as a second messenger]. 1987 Rinsho Byori pmid:3437533
Kawamura Y et al. [A simple measurement of plasma platelet-activating factor (PAF) acetylhydrolase, normal level of activity, and distribution among lipoprotein fractions]. 1987 Rinsho Byori pmid:3437547
Izumi T and Shimizu T [Biological regulation with platelet activating factor--molecular cloning and signal transduction of PAF]. 1994 Rinsho Ketsueki pmid:8028185
Nagata K et al. [Thrombotic thrombocytopenic purpura (TTP) with a remission following splenectomy after the failure of antiplatelet therapy and plasmapheresis]. 1984 Rinsho Ketsueki pmid:6542941
Asada Y [Inflammatory and immune responses in arterial thrombus formation]. 2005 Rinsho Ketsueki pmid:16447700
Kira J [Multiple sclerosis]. 2005 Rinsho Shinkeigaku pmid:16447761
Debek W et al. Luminol-chemiluminescence in free peritoneal cells in hemorrhagic shock in rats treated with PAF-receptor-antagonist BN 52021. 1995 Rocz. Akad. Med. Bialymst. pmid:8528982
Kirejczyk JK et al. Ginkgolide BN 52021 protects against hemorrhagic shock-induced renal injury in rats. 1995 Rocz. Akad. Med. Bialymst. pmid:8528996
Kirejczyk JK et al. Oxygen-derived free radicals in kidney in experimental hemorrhagic shock treated by PAF-receptor antagonist BN 52021. 1995 Rocz. Akad. Med. Bialymst. pmid:8528997
Gabryelewicz A Etiology and pathogenesis of acute pancreatitis--current view. 1995 Rocz. Akad. Med. Bialymst. pmid:8834603
Zăgrean L et al. Preliminary EEG study of protective effects of Tebonin in transient global cerebral ischemia in rats. 1998 Jan-Jun Rom J Physiol pmid:11000876
Kaminker AJ and Carreras LO [Physiopathology of thrombotic microangiopathy]. 1989 Sangre (Barc) pmid:2667170
Rotllan E et al. [Effect of PAF (platelet-activating factor) on hemostasis. Studies on endothelial cells and platelets]. 1993 Sangre (Barc) pmid:8390724
Meloni Bruneri LH and Barbieri D [Platelet aggregation after the reduction of nitro-blue tetrazolium by eosinophils]. 1985 Sangre (Barc) pmid:4071355
Rylander R Role of endotoxin and glucan for the development of granulomatous disease in the lung. 1989 Sarcoidosis pmid:2623374
Teles de Araújo A et al. Surfactant modifications and lipidic mediators in occupational lung diseases. 1989 Sarcoidosis pmid:2623375
Bottecchia D et al. Influence of the pure synthetic PAF (platelet aggregating factor) on clot retraction and platelet aggregation. 1984 Scand J Haematol pmid:6695148
Birk-Sørensen L et al. Platelet activating factor antagonism in pure skin flaps exposed to ischaemia-reperfusion injury. 1999 Scand J Plast Reconstr Surg Hand Surg pmid:10450571
Mastroroberto P et al. Elevated circulating levels of von Willebrand factor and D-dimer in patients with heart failure and mechanical prosthesis. 1996 Scand J Thorac Cardiovasc Surg pmid:8857679
Møller CH and Steinbrüchel DA Platelet function after coronary artery bypass grafting: is there a procoagulant activity after off-pump compared with on-pump surgery? 2003 Scand. Cardiovasc. J. pmid:12881156
Palmblad J et al. Interactions between alkylglycerols and human neutrophil granulocytes. 1990 Scand. J. Clin. Lab. Invest. pmid:2168089
Jørgensen L et al. Rabbit lung macrophages stimulate platelets in vitro as observed by density-gradient centrifugation and transmission electron microscopy. 1993 Scand. J. Clin. Lab. Invest. pmid:8272758
Atuma C et al. Helicobacter pylori extracts reduce gastric mucosal blood flow by a nitric oxide-independent but mast cell- and platelet-activating factor receptor-dependent pathway in rats. 1999 Scand. J. Gastroenterol. pmid:10636064
Wang LS et al. Effects of platelet activating factor, butyrate and interleukin-6 on cyclooxygenase-2 expression in human esophageal cancer cells. 2002 Scand. J. Gastroenterol. pmid:11989839
Sun Z et al. Effects of inhibition of PAF, ICAM-1 and PECAM-1 on gut barrier failure caused by intestinal ischemia and reperfusion. 2001 Scand. J. Gastroenterol. pmid:11218240
Denis MA et al. Increased response of blood eosinophils to various chemotactic agents in quiescent Crohn disease. 2001 Scand. J. Gastroenterol. pmid:11252412
Binnaka T et al. Gastric hemodynamic disturbance induced by hemorrhagic shock in rats. Role of platelet-activating factor. 1990 Scand. J. Gastroenterol. pmid:2359986
Gustafson C et al. Phospholipase C from Clostridium perfringens stimulates formation and release of platelet-activating factor (PAF-acether) in cultured intestinal epithelial cells (INT 407). 1991 Scand. J. Gastroenterol. pmid:1947765
Kald B et al. Phospholipase C from Clostridium perfringens stimulates acetyltransferase-dependent formation of platelet-activating factor in cultured intestinal epithelial cells (INT 407). 1994 Scand. J. Gastroenterol. pmid:8209184
Olanders K et al. Protective effects of N-acetyl-L-cysteine and platelet activating factor inhibition are not linked to intercellular adhesion molecule-1 expression after intestinal ischemia and reperfusion injury in rats. 2003 Scand. J. Gastroenterol. pmid:12825870
Berstad A et al. Effect of platelet-activating factor and its receptor antagonist, SRI 63-675, on gastric bleeding in rats. 1988 Scand. J. Gastroenterol. pmid:3262915
Binnaka T et al. Burn-induced gastric mucosal hemodynamic disturbance in the rat. Role of platelet-activating factor. 1992 Scand. J. Gastroenterol. pmid:1561532
Yoshida N et al. Pathogenesis of platelet-activating factor-induced gastric mucosal damage in rats. 1989 Scand. J. Gastroenterol. Suppl. pmid:2556790
Rachmilewitz D et al. Platelet-activating factor--a possible mediator in the pathogenesis of ulcerative colitis. 1990 Scand. J. Gastroenterol. Suppl. pmid:1972295
Kingsnorth AN Platelet-activating factor. 1996 Scand. J. Gastroenterol. Suppl. pmid:8865468
Iwai A et al. Role of PAF in ischemia-reperfusion injury in the rat stomach. 1989 Scand. J. Gastroenterol. Suppl. pmid:2595310
Binnaka T et al. Gastric mucosal damage induced in rats by intravenous administration of platelet-activating factor. 1989 Scand. J. Gastroenterol. Suppl. pmid:2595311
Hatakeyama K et al. Platelet activating factor induced gastric damage in rats: participation of increased gastric vascular permeability. 1989 Scand. J. Gastroenterol. Suppl. pmid:2595312
van der Poll T et al. Interleukin 10 release during endotoxaemia in chimpanzees: role of platelet-activating factor and interleukin 6. 1996 Scand. J. Immunol. pmid:8560191
Geffner JR et al. Interferon-gamma enhances PAF-acether production by stimulated human polymorphonuclear leucocytes. 1991 Scand. J. Immunol. pmid:1903211
Renkonen R et al. Lymphocyte binding to and penetration through vascular endothelium is stimulated by platelet-activating factor. 1989 Scand. J. Immunol. pmid:2602912